Link Library - My Woodcraft

Alleged links to violence (3)	Bias in evidence-based research (15)	Clinical Practice Issues and Guidelines (12)
Cost effectiveness of psychodynamic psychotherapy (18)	Dangers of outpatient commitment (1)	Dangers of psychiatric medications (22)
Effectiveness of psychodynamic treatment (51)	Efficacy over time vs. CBT (21)	How therapy changes the brain for the better (and trauma for the worse) (9)
Inadequacy of Diagnosis (4)	Increases in prescriptions over time (2)	Issues with research and evidence (3)
Medicalization & Stigma (12)	Medications: efficacy and side effects (8)	Mental Health Statistics and Trends (11)
Mentally ill more likely to be targets than perpetrators (9)	Need for longer-term treatment (9)	Other databases & libraries (8)
Parity Issues (21)	Partners (29)	Psychodynamic treatment mis-represented in training (6)
PTSD (6)	Treatment of choice for therapists (1)

Topics	Year	Reference	Name
Cost effectiveness of psychodynamic psychotherapy	2008	van Asselt, A. D., Dirksen, C. D., Arntz, A., Giesen-Bloo, J. H., Van Dyck, R., Spinhoven, P., et al. (2008). Out-patient psychotherapy for borderline personality disorder: Cost-effectiveness of schema-focused therapy v. transferencefocused psychotherapy. British Journal of Psychiatry, 192(6), 450-457.
Cost effectiveness of psychodynamic psychotherapy	2011	Dixon-Gordon, K.L., Turner, B.J., & Chapman, A.L. (2011). Psychotherapy for personality disorders. International Review of Psychiatry, 23, 292-302. DOI: 10.3109/09540261.2011.586992
Cost effectiveness of psychodynamic psychotherapy	2010	Lazar, S. G., ed. (2010). Psychotherapy is Worth It: A Comprehensive Review of its Cost-Effectiveness. Arlington, VA: American Psychiatric Publishing, Inc.
Cost effectiveness of psychodynamic psychotherapy	1999	Stevenson, J., & Meares, R. (1999). Psychotherapy with borderline patients: II. A preliminary cost benefit study. Australian and New Zealand Journal of Psychiatry, 33(4), 473-477.
Cost effectiveness of psychodynamic psychotherapy	2014	Lazar, S. G. (2014). The Cost-Effectiveness of Psychotherapy for the Major Psychiatric Diagnoses Psychodynamic Psychiatry. Psychodynamic Psychiatry 42.3:423-57.
Cost effectiveness of psychodynamic psychotherapy	1997	Lazar, S.G., & Gabbard, G.O. (1997). The cost-effectiveness of psychotherapy. Journal of Psychotherapy Practice and Research, 6, 307-314. doi: 9292445
Cost effectiveness of psychodynamic psychotherapy		Berghout CC, Zevalkink J, Hakkaart-Van Roijen, L.. The effects of long-term psychoanalytic treatment on healthcare utilization and work impairment and their associated costs. Journal of Psychiatric Practice. 16(4): 209-216. doi: 10.1097/01.pra.0000386907.99536.75.
Cost effectiveness of psychodynamic psychotherapy	2015	Author Wampold, B;, Imel, Z. (2015). The Great Psychotherapy Debate: The Evidence for What Makes Psychotherapy Work

Topics	Year	Reference	Name
Dangers of outpatient commitment	2001	Allen, M., & Smith, V.F. (2001). Opening Pandora’s box: The practical and legal dangers of involuntary outpatient commitment. Psychiatric Services, 52(3): 342346.

Topics	Year	Reference	Name
Dangers of psychiatric medications	2015	Iqbal, Usman, Phung-Anh Nguyen, Shabbir Syed-Abdul, Hsuan-Chia Yang, Chih-Wei Huang, Wen-Shan Jian, Min-Huei Hsu, Yun Yen, and Yu-Chuan Jack Li. (2015). "Is long-term use of benzodiazepine a risk for cancer?." Medicine 94, no. 6 (2015).
Dangers of psychiatric medications	2011	Whitaker, Robert (2011). Anatomy of an Epidemic : Magic Bullets, Psychiatric Drugs, and the Astonishing Rise of Mental Illness in America
Dangers of psychiatric medications	2016	Levingston, S. (2016). Antidepressants no more effective than placebo, leading researcher claims in new book. The Washington Post, 4 Feb 2010.
Dangers of psychiatric medications	2012	Morrison, A. P., Hutton, P., Shiers, D., & Turkington, D. (2012). Antipsychotics: Is it time to introduce patient choice? British Journal of Psychiatry, 201, 83–84.
Dangers of psychiatric medications	2016	Weintraub D, Chiang C, Kim H, et al. (2016). Association of Antipsychotic Use With Mortality Risk in Patients With Parkinson Disease. JAMA Neurol.
Dangers of psychiatric medications	2014	Author Gnaulati (2014). Back to Normal : Why Ordinary Childhood Behavior Is Mistaken for ADHD, Bipolar Disorder, and Autism Spectrum Disorder
Dangers of psychiatric medications	2011	Lepping, P., Sambhi, R. S., Whittington, R., Lane, S., & Poole, R. (2011). Clinical relevance of findings in trials of antipsychotics: Systematic review. British Journal of Psychiatry, 198(5), 341–345.
Dangers of psychiatric medications	2012	Harrow, M., Jobe, T. H., & Faull, R. N. (2012). Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20year longitudinal study. Psychological Medicine, 42(10), 2145–2155.
Dangers of psychiatric medications	2008	Kirsch, I., Deacon, B. J., HuedoMedina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine, 5(2), e45.
Dangers of psychiatric medications	2016	Lee, S.H., Paz-Filho, G., Mastronardi, C., Licinio, J. and Wong, M.L. (2016). Is increased antidepressant exposure a contributory factor to the obesity pandemic?. Translational Psychiatry, 6(3), p.e 75
Dangers of psychiatric medications	2017	Whitaker, R. (2017). Mad in America: Bad Science, Bad Medicine, and the Enduring Mistreatment of the Mentally Ill

Previous12345...1415Next